| 81 |
MDSC depletion during immunization with heat-killed Mycobacterium tuberculosis increases protection against BCG infection |
Department of Microbiology and Immunology |
2025 |
| 82 |
Metformin hydrochloride laden nanostructured lipid carriers: A promising strategy for skin diseases |
Department of Pharmaceutics |
2025 |
| 83 |
MicroRNA-155 Overexpression in Inflammatory Bowel Disease Patients: Potential Role in Inflammation and Immune Regulation |
Department of Microbiology and Immunology |
2025 |
| 84 |
Microwell-based spectrophotometric analysis of pemigatinib via formation of charge transfer complexes: Eco-friendly and high-throughput methods |
Department of Pharmaceutical Analytical Chemistry |
2025 |
| 85 |
Mizolastine-loaded spanlastics for treatment of atopic dermatitis: immunomodulatory approach for management of inflammation |
Department of Industrial Pharmacy |
2025 |
| 86 |
N-substituted-5-[(2,5-dihydroxybenzyl)amino]salicylamides as lavendustin analogs: antiproliferative activity, COMPARE analyses, mechanistic, docking, ADMET and toxicity studies |
Department of Pharmaceutical Organic Chemistry |
2025 |
| 87 |
Near-infrared carbon dots enable ultra-sensitive fluorometric detection of belzutifan: a novel approach for real-time therapeutic drug monitoring in cancer treatment |
Department of Pharmaceutical Analytical Chemistry |
2025 |
| 88 |
Neuroprotective Effect of Empagliflozin/Rivastigmine in Alzheimer's Disease Rat Model: Optimization of Multifaceted Mechanism of Action |
Department of Pharmacology |
2025 |
| 89 |
New antiproliferative 1,3,4-oxadiazole/benzimidazole derivatives: Design, synthesis, and biological evaluation as dual EGFR and BRAFV600E inhibitors |
Department of Pharmaceutical Organic Chemistry |
2025 |
| 90 |
New ionic liquid forms of antituberculosis drug combinations for optimized stability and dissolution |
Department of Pharmaceutics |
2025 |